...
首页> 外文期刊>Thorax: The Journal of the British Thoracic Society >Effect of a spacer on pulmonary aerosol deposition from a jet nebuliser during mechanical ventilation.
【24h】

Effect of a spacer on pulmonary aerosol deposition from a jet nebuliser during mechanical ventilation.

机译:在机械通气过程中,垫片对喷射雾化器的肺气溶胶沉积的影响。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

BACKGROUND--Several factors have been identified which improve nebulised aerosol delivery in vitro. One of these is the addition of a spacer to the ventilator circuit which improves aerosol delivery from a jet nebuliser to a model lung by approximately 30%. The current study was designed to demonstrate whether similar improvements could be demonstrated in vivo. METHODS--Ten patients (seven men) were studied during mechanical ventilation (Siemens Servo 900C) after open heart surgery. Aerosol was delivered using a Siemens Servo 945 nebuliser system (high setting) driving a System 22 Acorn jet nebuliser (Medic-Aid) containing 3 ml technetium-99m labelled human serum albumin (99mTc-HSA (50 micrograms); activity in the first nebulisation, 90 MBq; in the second nebulisation, 185 MBq). Central and peripheral lung aerosol deposition and the time to complete deposition were measured using a gamma camera and compared when the nebuliser was connected to the inspiratory limb using a simple T-piece or a 600 ml spacer. RESULTS--The addition of the spacer increased total lung deposition (mean (SD) percentage initial nebuliser activity) from 2.2 (0.7)% to 3 (0.8)%. There was no difference in the time required to complete nebulisation (18.2 min v 18.3 min respectively for T-piece and spacer) or in the retention of activity in the nebuliser (46.2% v 47.1% respectively). CONCLUSIONS--The combination of a spacer with a jet nebuliser increased lung deposition by 36% in mechanically ventilated patients and is a simple way of increasing drug deposition or reducing the amount of an expensive drug required for nebulisation.
机译:背景技术-已经确定了几种因素可以改善体外雾化气雾剂的输送。其中之一是在呼吸机回路中增加一个垫片,该垫片可将从喷射雾化器到模型肺的气溶胶输送量提高约30%。当前的研究旨在证明是否可以在体内证明类似的改善。方法-对10例患者(七名男性)进行了心脏直视手术后的机械通气(Siemens Servo 900C)。使用Siemens Servo 945雾化器系统(高温)输送气雾剂,该系统驱动System 22 Acorn喷射雾化器(Medic-Aid),其中包含3 ml net 99m标记的人血清白蛋白(99mTc-HSA(50微克);在第一次雾化中具有活性,90 MBq;在第二个雾化中为185 MBq)。使用伽玛相机测量中枢和外周肺气溶胶沉积以及完成沉积的时间,并使用简单的T形件或600 ml垫片将雾化器连接到吸气肢体时进行比较。结果-间隔物的添加使总肺部沉积(平均初始雾化器活性百分比)从2.2(0.7)%增加到3(0.8)%。完成雾化所需的时间(T型和垫片分别为18.2分钟对18.3分钟)或雾化器中的活性保留时间(分别为46.2%对47.1%)没有差异。结论-间隔器与喷射雾化器的组合在机械通气患者中使肺部沉积增加了36%,是增加药物沉积或减少雾化所需昂贵药物量的简单方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号